Omkar Pharmachem Limited (BOM:532167)
7.45
-0.12 (-1.59%)
At close: Sep 11, 2026
Omkar Pharmachem Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 75 | 297 | 303 | 227 | 252 | 206 | |
Market Cap Growth | -70.85% | -1.67% | 33.45% | -10.08% | 22.55% | -1.44% |
Enterprise Value | 73 | 297 | 304 | 231 | 259 | 214 |
Last Close Price | 7.45 | 29.50 | 30.00 | 22.48 | 25.00 | 20.40 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 88.32 | 244.23 | 150.58 | 119.88 | 127.45 | 112.35 |
PS Ratio | 17.89 | 63.97 | 56.02 | 41.98 | 46.69 | 38.10 |
PB Ratio | 0.21 | 0.81 | 3.21 | 2.46 | 2.79 | 2.33 |
P/TBV Ratio | 0.21 | 0.81 | 3.21 | 2.46 | 2.79 | 2.33 |
P/FCF Ratio | 32.88 | 130.18 | 126.31 | 79.18 | 91.37 | 104.96 |
P/OCF Ratio | 32.88 | 130.18 | 124.23 | 76.69 | 91.37 | 101.44 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 17.37 | 63.84 | 56.25 | 42.74 | 47.92 | 39.69 |
EV/EBITDA Ratio | 63.63 | 180.14 | 104.89 | 81.52 | 83.24 | 79.76 |
EV/EBIT Ratio | 65.31 | 183.37 | 106.62 | 82.90 | 83.97 | 80.33 |
EV/FCF Ratio | 31.93 | 129.92 | 126.83 | 80.61 | 93.80 | 109.34 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | - | - | 0.01 | 0.03 | 0.07 | 0.11 |
Debt / EBITDA Ratio | - | - | 0.41 | 1.07 | 2.00 | 3.46 |
Debt / FCF Ratio | - | - | 0.50 | 1.06 | 2.25 | 4.74 |
Net Debt / Equity Ratio | -0.01 | -0.01 | 0.00 | 0.03 | 0.05 | 0.08 |
Net Debt / EBITDA Ratio | -1.89 | -1.32 | 0.03 | 0.82 | 1.57 | 2.67 |
Net Debt / FCF Ratio | - | -0.95 | 0.04 | 0.81 | 1.77 | 3.67 |
Asset Turnover | - | 0.02 | 0.06 | 0.06 | 0.06 | 0.06 |
Quick Ratio | - | 5.94 | 1.56 | 0.50 | 0.26 | 0.22 |
Current Ratio | - | 5.96 | 1.56 | 0.51 | 0.38 | 0.30 |
Return on Equity (ROE) | - | 0.53% | 2.15% | 2.07% | 2.21% | 2.09% |
Return on Assets (ROA) | - | 0.44% | 1.85% | 1.80% | 1.97% | 1.71% |
Return on Invested Capital (ROIC) | 0.22% | 0.53% | 2.24% | 2.19% | 2.41% | 2.43% |
Return on Capital Employed (ROCE) | - | 0.40% | 3.00% | 3.00% | 3.40% | 3.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.13% | 0.41% | 0.66% | 0.83% | 0.78% | 0.89% |
FCF Yield | 3.04% | 0.77% | 0.79% | 1.26% | 1.09% | 0.95% |